Frontlight ResearchEarly access
Triple-negative breast cancer trials, also abroad
477 open Triple-negative breast cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) has 10 sites in Spain and runs in 41 countries. If a site near you is full, another one may still take people.
See A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) in all 41 countries